ArticleInnovation (Cambridge (Mass.))2025
A high-definition spatiotemporal transcriptomic atlas of mammalian kidney development.
Article in Innovation (Cambridge (Mass.)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Spatiotemporal dynamics of renal distal convoluted tubule dilatation and cyst formation in nephronophthisis type 1 mice.Renal failure · 2026Article
- Bridging Kidney Organoid Innovation and Regenerative Medicine: Current Advances and Future Directions.Cell proliferation · 2026Review
- A spatiotemporal transcriptomic atlas of porcine (Sus scrofa) female early gonadal development.Communications biology · 2026Article
- Dose-Dependent and Non-Autonomous Signaling in CAKUT: A Lineage-Specific Framework from Conditional Knockout Studies.Biomolecules · 2026Review
- stSCI: A multi-task learning framework for integrative analysis of single-cell and spatial transcriptomics data.Innovation (Cambridge (Mass.)) · 2026Article
- Phenotypes of Hereditary Diseases Associated With Rauch-Steindl Syndrome.Human mutation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The structural composition of organs undergoes significant transformations during organogenesis, laying the foundation for their eventual functional architecture. In contrast, adult organs maintain structural homeostasis. However, the dynamics of organ structure during the organogenesis and homeostasis stages remain poorly understood. Here, we present a spatially resolved transcriptome atlas at single-cell resolution to explore the establishment and maintenance of kidney structure in mice. Our analysis reveals 40 migration-related cell-cell communication events during kidney organogenesis. Contrary to the traditional two-layer model (cortex and medulla), we demonstrate that the kidney develops a five-layer structure over time. Mechanistically, migration-related cell-cell communication drives this structural formation, with ephrin-A5 (Efna5) playing a key role in forming three distinct layers within the medulla. The spatial distribution of specific cell types and their gene expression patterns within these five layers likely enhances renal adaptation to hypoxic and hyperosmotic environments. Furthermore, Frizzled 4 receptor (Fzd4) is critical for the morphogenesis of the U-shaped loop of Henle (LoH). In the adult stage, when structural homeostasis prevails, only three migration-related ligand-receptor pairs are observed, and a stable four-layer structure is maintained due to the absence of progenitor cells. Overall, our findings illustrate the role of intercellular communication in driving the transition from structural establishment during organogenesis to stable maintenance in homeostasis. These insights provide new avenues for advancing organ regeneration strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.